Anti-JAK3/ JAK-3/ JAK-3_HUMAN monoclonal antibody

Anti-JAK3/ JAK-3/ JAK-3_HUMAN antibody for FACS & in-vivo assay

Target products collectionGo to JAK-3/JAK3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T23172-Ab-1/ GM-Tg-hg-T23172-Ab-2Anti-Human JAK-3/JAK3 monoclonal antibodyHuman
GM-Tg-rg-T23172-Ab-1/ GM-Tg-rg-T23172-Ab-2Anti-Rat JAK-3/JAK3 monoclonal antibodyRat
GM-Tg-mg-T23172-Ab-1/ GM-Tg-mg-T23172-Ab-2Anti-Mouse JAK-3/JAK3 monoclonal antibodyMouse
GM-Tg-cynog-T23172-Ab-1/ GM-Tg-cynog-T23172-Ab-2Anti-Cynomolgus/ Rhesus macaque JAK-3/JAK3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T23172-Ab-1/ GM-Tg-felg-T23172-Ab-2Anti-Feline JAK-3/JAK3 monoclonal antibodyFeline
GM-Tg-cang-T23172-Ab-1/ GM-Tg-cang-T23172-Ab-2Anti-Canine JAK-3/JAK3 monoclonal antibodyCanine
GM-Tg-bovg-T23172-Ab-1/ GM-Tg-bovg-T23172-Ab-2Anti-Bovine JAK-3/JAK3 monoclonal antibodyBovine
GM-Tg-equg-T23172-Ab-1/ GM-Tg-equg-T23172-Ab-2Anti-Equine JAK-3/JAK3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T23172-Ab-1/ GM-Tg-hg-T23172-Ab-2; GM-Tg-rg-T23172-Ab-1/ GM-Tg-rg-T23172-Ab-2;
GM-Tg-mg-T23172-Ab-1/ GM-Tg-mg-T23172-Ab-2; GM-Tg-cynog-T23172-Ab-1/ GM-Tg-cynog-T23172-Ab-2;
GM-Tg-felg-T23172-Ab-1/ GM-Tg-felg-T23172-Ab-2; GM-Tg-cang-T23172-Ab-1/ GM-Tg-cang-T23172-Ab-2;
GM-Tg-bovg-T23172-Ab-1/ GM-Tg-bovg-T23172-Ab-2; GM-Tg-equg-T23172-Ab-1/ GM-Tg-equg-T23172-Ab-2
Products NameAnti-JAK-3/JAK3 monoclonal antibody
Formatmab
Target NameJAK-3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-JAK-3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species JAK3/ JAK-3/ JAK-3_HUMAN VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T23172
    Target NameJAK-3
    Gene ID3718,16453,25326,720040,610004,101092339,538276,100147451
    Gene Symbol and Synonymsfae,JAK-3,JAK3,JAK3_HUMAN,JAKL,L-JAK,LJAK,RATJAK3,wil
    Uniprot AccessionP52333,Q63272
    Uniprot Entry NameJAK3_HUMAN,JAK3_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000105639
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: JAK-3, gene name: JAK3, also named as JAK-3_HUMAN, JAKL, L-JAK, LJAK, JAK3. The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.